‘Trying to Recapture the Magic’: The Strategy Behind the Pharma M&A Rush

In the midst of an M&A frenzy in the global pharmaceutical industry, Wharton experts advise companies to keep a watchful eye on runaway valuations and post-merger integration.Read More